Cardio-Diabetes
Advanced antidiabetic oral solids, antihypertensives, statins, and novel Fixed Dose Combinations (FDCs).
India's Leading CDMO Partner • IPM Innovation
Evaron : A Trusted Partner in Pharmaceutical Excellence
Evaron is India's largest Contract Development and Manufacturing Organization (CDMO), driving pharmaceutical innovation and high-velocity manufacturing across the Indian Pharmaceutical Market (IPM) and global supply chains.
3,300+
Commercial Formulations
Across 60+ dosage formats developed since inception
1800+
Innovative Formulations
Supported by 18+ versatile R&D platform technologies
3 + 1
Plants & R&D Center
3 Manufacturing Units + 1 Dedicated R&D Center (DSIR Approved)
Billions
Annual Unit Throughput
High-capacity operations powered by seasoned technical talent
Strategic CDMO Partner
Shaping the Future of Healthcare with Innovation, Quality & Trust
Since our inception, Evaron has developed over 3,300 commercialized formulations across 60+ dosage forms, catering to critical therapeutic categories in human and animal health. Our robust R&D capabilities have propelled 1800+ innovative formulations, supported by 18+ versatile platform technologies that enhance product development, bioavailability, and market differentiation.
With 3 state-of-the-art manufacturing units and a dedicated R&D center recognized and approved by the Department of Scientific and Industrial Research (DSIR), Government of India—we operate at the forefront of contemporary pharmaceutical science. Our experienced technical personnel and automated cleanroom bays enable an annual production capacity running into billions of formulation units.
National Recognition
Govt. of India
DSIR-Approved R&D Center
Our dedicated research center is recognized and approved by the Department of Scientific and Industrial Research (DSIR), Government of India, validating our scientific methodology and novel formulation pipeline.
Full Regulatory Support
DCGI & Global CTD
Bioequivalence & Clinical Trials
From pre-clinical formulation development and pharmacokinetic BE studies to Phase-trial compliance and DCGI dossier filings, we deliver 360-degree regulatory execution.
Therapeutic Reach
Key Therapeutic Areas
Our 3,300+ formulations power commercial portfolios across the major high-growth clinical segments in the Indian Pharmaceutical Market (IPM).
Neurology & CNS
Neuroprotective formulations, anticonvulsants, mood regulators, and brain bioavailability enhancers.
Gynecology
Women's health therapeutic range, hormonal formulations, fertility enhancers, and maternal care.
Nephrology
Renal therapeutics, phosphate binders, electrolyte stabilizers, and chronic kidney disease management.
Anti-Infectives
Broad-spectrum antibiotics, antifungals, antivirals, and dedicated dry powder / liquid suspension lines.
Respiratory
Bronchodilators, antihistamines, mucolytics, and targeted pulmonary delivery therapeutics.
Analgesics & NSAIDs
Fast-acting and sustained-release pain management formulations, anti-inflammatories, and muscle relaxants.
Multi-Vitamins & Nutrition
Nutraceuticals, antioxidant compounds, therapeutic multivitamin syrups, and specialized chewables.
Comprehensive Solution Provider
Full-Spectrum CDMO Capabilities
We manage the complete formulation life cycle—transforming molecules into market-ready brands backed by clinical validation and regulatory clearances.
Stage 01
Formulation Development
1800+ innovative formulations engineered across 18+ platform technologies, offering superior stability, masking, and drug release profiles.
18+ Platform Technologies
Stage 02
Bioequivalence Studies
Conducting in-vivo and in-vitro bioequivalence (BE) studies, comparative dissolution profiles, and clinical trials under strict GCP compliance.
GCP & GLP Compliance
Stage 03
DCGI Regulatory Clearances
Specialized capability in securing official Drug Controller General of India (DCGI) approvals for novel Fixed Dose Combinations (FDCs) and new molecules.
New FDC Registrations
Stage 04
Commercial Production
Annual production capacity of billions of formulation units, backed by high-speed blister packing, serialization, and nationwide logistics.
Billions Annual Capacity
Production & Scientific Scale
Manufacturing & R&D Footprint
Operating 3 state-of-the-art production hubs alongside a dedicated scientific research center.
Manufacturing Infrastructure
3 Units
3 State-of-the-Art Production Units
Engineered to WHO-GMP standards with automated HVAC air classification, high-speed tablet compression, capsule encapsulation, and liquid fill lines:
- Unit I (Bahadrabad, Haridwar): Flagship WHO-GMP Solid Orals & Formulations
- Unit II (Puhana, Roorkee): Liquid Orals, Formulations & Sterile Solutions
- Unit III (Ramghat Road, Aligarh): High-Capacity Formulations & Bulk Distribution
Scientific Discovery
1 Center
Dedicated R&D Center (DSIR Approved)
Driving proprietary formula design, pharmacokinetic enhancement, and stability studies with analytical precision:
- DSIR Recognition: Approved and recognized by Department of Scientific and Industrial Research, Govt. of India
- 18+ Platform Technologies: Taste-masking, modified-release, osmotic and bilayer systems
- Accelerated Stability Testing: ICH Q1A compliance chambers for global dossier readiness
- Analytical GLP Instrumentation: HPLC, GC, FTIR, dissolution testers and particle counters
Strategic Differentiation
Why Choose Us?
Evaron stands at the forefront of pharmaceutical innovation, offering high-quality products and reliable solutions. With a commitment to excellence and customer satisfaction, we deliver trusted healthcare solutions globally.
Timeline
A legacy of excellence, growth, and innovation over time.
Our Partners
Trusted collaborations driving success across the pharmaceutical industry.
Global Presence
Expanding worldwide with a strong footprint in healthcare.
Careers
Empowering talent through opportunities, growth, and excellence.
Manufacturing
State-of-the-art facilities ensuring precision and high quality.
R&D
Innovative research fueling next-generation pharmaceutical advancements.
Quality
Uncompromising standards ensuring safety, efficacy, and compliance.
Regulatory
Strict adherence to global compliance and industry regulations.
Innovation
Pioneering innovative solutions for a healthier, brighter future.
Investors
Trusted Partnerships for Sustainable and Long-Term Growth
Partner With India's Leading CDMO
At Evaron, we are committed to delivering excellence through innovation, quality, and trust. Let’s collaborate to shape the future of healthcare with safe, effective, and cutting-edge pharmaceutical formulations.